BOSTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
Compass Diversified Preferred 7.875% C Shares offer high yield income and stability, generating over 51% return for Hidden Dividend Stocks Plus subscribers through attractive quarterly dividends. CODI
Compass Group PLC (OTCPK:CMPGF) Q4 2024 Results Conference Call November 26, 2024 4:00 AM ET Company Participants Dominic Blakemore - Group CEO & Director Petros Parras - Group CFO & Director Conferen
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass, Intertek, Safestore and Topps Tiles are among a string on companies set to report from London on Tuesday, before HP and Crowdstrike across the Atlantic.
Robert Reffkin, Compass co-founder and CEO, joins CNBC's 'Squawk on the Street' to discuss the state of the real estate market, where inventory is building, and more.
Compass (COMP) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that ma
DALLAS--(BUSINESS WIRE)--Generational Capital Markets (GCM) Member FINRA/SIPC and a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its clien
Compass has emerged as a market leader amid industry volatility, gaining market share and growing revenue while the real estate sector declines. The company's Q3 results showed 12% y/y revenue growth
LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced
BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
Investors interested in stocks from the Retail - Restaurants sector have probably already heard of Compass Group PLC (CMPGY) and Shake Shack (SHAK). But which of these two stocks is more attractive to
Does Compass, Inc. (COMP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Compass (COMP) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still tradin
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE